These results suggest that PRELP mRNA expression is suppressed in ovarian cancer, which is not dependent on genetic deletion and mutation but rather epigenetic mechanisms, such as DNA methylation or histone modification. This evidence concerns the gene PRELP and ovarian carcinoma.